Important regulatory news last week included Otsuka gaining accelerated Food and Drug Administration approval for its Voyxact (sibeprenlimab) for immunoglobulin A nephrology, India’s Sun Pharma for ...

International understanding of China’s arrival as a leading player on the world stage as an innovator of new medicines is now ...

India’s pharmaceutical sector is witnessing global majors deepening their footprint in advanced therapies. The Central Drugs ...